« Return to News | CROs/Service Providers

TranScrip Partners announce U.S. expansion

Monday, April 8, 2013 09:39 AM

TranScrip Partners, a U.K.-based CRO, has created a U.S. office. The U.S. branch of TranScrip Partners will be led by Glenn Tillotson, a pharmaceutical expert with 25 years' industry experience and a successful track record in drug development and life cycle management.

The expansion of TranScrip Partners to the U.S. follows the opening of offices in Australia late last year and marks an important milestone in the expansion of TranScrip Partners.

"Establishing TranScrip's presence in the U.S. will allow us to better support our clients and their global drug development programs and will add to the depth and breadth of our expertise in drug development and commercialization," said Dr. Flic Gabbay, managing partner of TranScrip Partners.

TranScrip Partners supports biopharmaceutical product development and life-cycle management across a client base of over 80 companies. It challenges the traditional CRO model by offering both top-level therapeutic expertise in overcoming the hurdles encountered from translational medicine to successful registration and market access and the staff to support the projects. Services offered by TranScrip Partners include development and market positioning strategies for early molecules as well as tailored support in drug development, medical affairs, pharmacovigilance, regulatory and medical writing during pre- and post-approval.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.